Close

Lemelson Capital Makes Short Case Against Ligand Pharma (LGND)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. GM
2. TSLA
3. SPY
4. SHW
5. SPOT
6. AAPL
7. NVDA
8. AMZN
9. MINN
10. MTTR


Go back to Lemelson Capital Makes Short Case Against Ligand Pharma (LGND)
LIGAND PHARMA (NASDAQ: LGND) Delayed: 70.35 +1.82 (2.66%)
Previous Close $68.53    52 Week High $139.79 
Open $68.50    52 Week Low $82.07 
Day High $70.80    P/E 163.60 
Day Low $68.50    EPS $0.43 
Volume 48,850